JP2004501183A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004501183A5 JP2004501183A5 JP2002504979A JP2002504979A JP2004501183A5 JP 2004501183 A5 JP2004501183 A5 JP 2004501183A5 JP 2002504979 A JP2002504979 A JP 2002504979A JP 2002504979 A JP2002504979 A JP 2002504979A JP 2004501183 A5 JP2004501183 A5 JP 2004501183A5
- Authority
- JP
- Japan
- Prior art keywords
- particles
- item
- pharmaceutical composition
- excipient
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 description 36
- 238000000034 method Methods 0.000 description 20
- 239000000546 pharmaceutical excipient Substances 0.000 description 20
- 239000000463 material Substances 0.000 description 17
- 239000008194 pharmaceutical composition Substances 0.000 description 15
- 239000002131 composite material Substances 0.000 description 10
- 238000003801 milling Methods 0.000 description 5
- 238000000227 grinding Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940112141 dry powder inhaler Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00113608 | 2000-06-27 | ||
| EP00113608.4 | 2000-06-27 | ||
| GB0029263.1 | 2000-11-30 | ||
| GB0029263A GB0029263D0 (en) | 2000-11-30 | 2000-11-30 | Method of making particles for use in a pharmaceutical composition |
| PCT/GB2001/001732 WO2001078694A2 (en) | 2000-04-17 | 2001-04-17 | Formulations for use in inhaler devices |
| GBPCT/GB01/01732 | 2001-04-17 | ||
| PCT/GB2001/002860 WO2002000197A1 (en) | 2000-06-27 | 2001-06-27 | Method of making particles for use in a pharmaceutical composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004501183A JP2004501183A (ja) | 2004-01-15 |
| JP2004501183A5 true JP2004501183A5 (cg-RX-API-DMAC10.html) | 2008-07-10 |
| JP5698423B2 JP5698423B2 (ja) | 2015-04-08 |
Family
ID=26071085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002504979A Expired - Lifetime JP5698423B2 (ja) | 2000-06-27 | 2001-06-27 | 医薬組成物で使用するための粒子の製造法 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US7744855B2 (cg-RX-API-DMAC10.html) |
| EP (3) | EP1913939B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP5698423B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR100949539B1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN100551358C (cg-RX-API-DMAC10.html) |
| AT (1) | ATE378039T1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2413692C (cg-RX-API-DMAC10.html) |
| DE (1) | DE60131399T3 (cg-RX-API-DMAC10.html) |
| DK (1) | DK1913939T3 (cg-RX-API-DMAC10.html) |
| ES (2) | ES2292598T3 (cg-RX-API-DMAC10.html) |
| IL (2) | IL153705A0 (cg-RX-API-DMAC10.html) |
| PT (2) | PT1913939T (cg-RX-API-DMAC10.html) |
| WO (1) | WO2002000197A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (96)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501841D0 (en) * | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| GB0009468D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formulations for use in inhaler devices |
| PE20011227A1 (es) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| GB0009469D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
| ES2292598T3 (es) * | 2000-06-27 | 2008-03-16 | Vectura Limited | Metodo para producir particulas para usar en una composicion farmaceutica. |
| US8580306B2 (en) * | 2000-11-30 | 2013-11-12 | Vectura Limited | Particles for use in a pharmaceutical composition |
| EP2283817B1 (en) * | 2000-11-30 | 2016-05-18 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| GB0208742D0 (en) * | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
| EP1487417A4 (en) | 2001-09-17 | 2010-03-17 | Glaxo Group Ltd | DRY POWDER DRUG FORMULATIONS |
| US20060147389A1 (en) * | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
| CN102688224A (zh) * | 2003-04-14 | 2012-09-26 | 维克特拉有限公司 | 用于提高剂量效率的药物组合物和装置 |
| US7094545B2 (en) | 2003-04-30 | 2006-08-22 | Ferring Bv | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| WO2005000267A2 (en) * | 2003-05-28 | 2005-01-06 | Nektar Therapeutics | Spray drying of an alcoholic aqueous solution for the manufacture of a water-insoluble active agentmicroparticle with a partial or complete amino acid and/or phospholipid coat |
| JP2009513529A (ja) * | 2003-07-11 | 2009-04-02 | グラクソ グループ リミテッド | ステアリン酸マグネシウムを含む医薬製剤 |
| ATE301990T1 (de) | 2003-07-25 | 2005-09-15 | Ferring Bv | Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung |
| KR20060117909A (ko) * | 2003-09-15 | 2006-11-17 | 벡투라 리미티드 | 폐 흡입에 의한 조루 치료용 제약학적 조성물 |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| GB0324918D0 (en) * | 2003-10-24 | 2003-11-26 | Glaxo Group Ltd | Composition |
| US7018653B2 (en) | 2003-12-29 | 2006-03-28 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
| DE102004011512B4 (de) * | 2004-03-08 | 2022-01-13 | Boehringer Ingelheim Vetmedica Gmbh | Pharmazeutische Zubereitung enthaltend Pimobendan |
| US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
| EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| GB0409703D0 (en) | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
| GB0425758D0 (en) * | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| GB0426301D0 (en) * | 2004-11-30 | 2004-12-29 | Vectura Ltd | Pharmaceutical formulations |
| WO2006087919A1 (ja) * | 2005-01-28 | 2006-08-24 | Takeda Pharmaceutical Company Limited | 難水溶性物質含有微細化組成物 |
| BRPI0606364A2 (pt) | 2005-02-10 | 2010-03-23 | Glaxo Group Ltd | processo para formar lactose adequada para uso em uma formulaÇço farmacÊutica |
| ITMI20051999A1 (it) * | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
| GB0613161D0 (en) | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
| JP5508003B2 (ja) | 2006-06-30 | 2014-05-28 | アイスイティカ ピーティーワイ リミテッド | ナノ粒子状の形態における生物学的に活性な化合物の調製のための方法 |
| EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| HUE027537T2 (en) * | 2007-09-03 | 2016-10-28 | Nanotherapeutics Inc | Granular preparations for the administration of poorly soluble drugs |
| EP2080508A1 (en) | 2008-01-15 | 2009-07-22 | CHIESI FARMACEUTICI S.p.A. | Dry powder formulation comprising an anticholinergic drug |
| EP2296628B1 (en) | 2008-05-22 | 2014-05-14 | 3M Innovative Properties Company | Process for manufacturing flowable powder drug compositions |
| US9956170B2 (en) | 2008-06-26 | 2018-05-01 | 3M Innovative Properties Company | Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof |
| EP2309984B1 (en) | 2008-07-02 | 2018-04-11 | 3M Innovative Properties Company | Method of making a dry powder pharmaceutical composition |
| WO2010060874A1 (en) | 2008-11-25 | 2010-06-03 | Boehringer Ingelheim Vetmedica Gmbh | Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy |
| JP5671001B2 (ja) | 2009-03-26 | 2015-02-18 | パルマトリックス，インコーポレイテッド | 肺疾患を治療するための乾燥粉末製剤および方法 |
| CA2759109A1 (en) | 2009-04-24 | 2010-10-28 | Iceutica Pty Ltd | A solid dosage form of ciprofloxacin having small particle size and improved powder handling characteristics |
| KR20160148041A (ko) * | 2009-04-24 | 2016-12-23 | 아이슈티카 피티와이 리미티드 | 캅셀화된 나노입자의 상업적 규모의 생산 |
| NZ710384A (en) | 2009-04-24 | 2017-03-31 | Iceutica Pty Ltd | A novel formulation of indomethacin |
| MX2011011123A (es) * | 2009-04-24 | 2011-11-04 | Schering Corp | Formulaciones de aglomerado utiles en inhaladores de polvo seco. |
| GB0921481D0 (en) | 2009-12-08 | 2010-01-20 | Vectura Ltd | Process and product |
| CA2784207C (en) * | 2009-12-14 | 2018-06-05 | Chiesi Farmaceutici S.P.A. | Antibiotic microparticles for inhalation |
| RU2580312C2 (ru) * | 2010-04-21 | 2016-04-10 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Способ получения частиц с пониженным электростатическим зарядом |
| US9228785B2 (en) | 2010-05-04 | 2016-01-05 | Alexander Poltorak | Fractal heat transfer device |
| CA2803418A1 (en) | 2010-06-22 | 2011-12-29 | Chiesi Farmaceutici S.P.A. | Dry powder formulation comprising an antimuscarinic drug |
| EA024922B1 (ru) | 2010-08-03 | 2016-11-30 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Сухой порошковый препарат, содержащий ингибитор фосфодиэстеразы |
| US8758824B2 (en) | 2010-08-30 | 2014-06-24 | Pulmatrix, Inc. | Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
| WO2012030664A1 (en) | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
| PT2621488T (pt) | 2010-09-29 | 2019-02-12 | Pulmatrix Operating Co Inc | Pós secos catiónicos |
| EP4008326A1 (en) | 2010-09-29 | 2022-06-08 | Pulmatrix Operating Company, Inc. | Monovalent metal cation dry powders for inhalation |
| TW201304822A (zh) | 2010-11-15 | 2013-02-01 | Vectura Ltd | 組成物及用途 |
| WO2012073025A1 (en) | 2010-11-30 | 2012-06-07 | Vectura Limited | Glucosaminoglucans such as heparin for use in the treatment of pulmonary inflammation such as copd |
| US20150136130A1 (en) | 2012-02-29 | 2015-05-21 | Pulmatrix, Inc. | Inhalable dry powders |
| US10398705B2 (en) | 2012-03-15 | 2019-09-03 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
| KR20140147891A (ko) * | 2012-04-13 | 2014-12-30 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 응집체 입자 |
| KR20150135328A (ko) | 2013-04-01 | 2015-12-02 | 풀매트릭스 인코퍼레이티드 | 티오트로피움 건조 분말 |
| ITMI20130571A1 (it) * | 2013-04-10 | 2014-10-11 | Zambon Spa | Composizione farmaceutica contenente budesonide e formoterolo |
| ITMI20130572A1 (it) | 2013-04-10 | 2014-10-11 | Eratech Srl | Composizione comprendente almeno due polveri secche ottenute per spray dry per aumentare la stabilita' della formulazione |
| LT3019153T (lt) * | 2013-07-11 | 2018-11-26 | Chiesi Farmaceutici S.P.A. | Sausų miltelių kompozicija, apimanti anticholinerginį agentą, kortikosteroidą ir beta-adrenerginį agentą, skirta įvedimui inhaliacijos pagalba |
| AU2014292086B2 (en) | 2013-07-19 | 2019-08-08 | Boehringer Ingelheim Vetmedica Gmbh | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| MX375936B (es) | 2013-12-04 | 2025-03-07 | Boehringer Ingelheim Vetmedica Gmbh | Composiciones farmaceuticas mejoradas de pimobendan. |
| EP3107548B8 (en) | 2014-02-20 | 2022-07-20 | Otitopic Inc. | Dry powder formulations for inhalation |
| US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
| CA2991760C (en) | 2014-07-31 | 2025-05-06 | Aspeya US Inc. | DRY INHALATION POWDER FORMULATIONS |
| KR102462058B1 (ko) | 2014-10-08 | 2022-11-01 | 잠본쏘시에떼퍼아찌오니 | 제제의 안정성을 증가시키기 위해 분무 건조에 의해 수득된 1종 이상의 건조 분말을 포함하는 조성물 |
| ES2971768T3 (es) * | 2014-10-08 | 2024-06-06 | Zambon Spa | Composición farmacéutica que contiene budesonida y formoterol |
| AU2015338717B2 (en) | 2014-10-31 | 2018-12-20 | Glaxosmithkline Intellectual Property Development Limited | Powder formulation |
| MA40910A (fr) * | 2014-11-07 | 2017-09-12 | Civitas Therapeutics Inc | Poudres de rapamycine pour administration pulmonaire |
| WO2017035408A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
| CN121974842A (zh) | 2016-05-10 | 2026-05-05 | C4医药公司 | 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体 |
| MX2018016046A (es) | 2016-06-27 | 2019-05-02 | Achillion Pharmaceuticals Inc | Quinazolina y compuestos indol para tratar trastornos medicos. |
| EP3485215B1 (en) | 2016-07-12 | 2023-06-07 | Alexander Poltorak | System and method for maintaining efficiency of a heat sink |
| CA3053818A1 (en) | 2017-03-01 | 2018-09-07 | Achillion Pharmaceuticals, Inc. | Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders |
| EP4717317A3 (en) | 2017-06-20 | 2026-06-03 | C4 Therapeutics, Inc. | N/o-linked degrons and degronimers for protein degradation |
| WO2019009335A1 (ja) * | 2017-07-04 | 2019-01-10 | 村上 正裕 | 微粒子の製造方法及び微粒子 |
| CN111902141A (zh) | 2018-03-26 | 2020-11-06 | C4医药公司 | 用于ikaros降解的羟脑苷脂结合剂 |
| EP3841086B1 (en) | 2018-08-20 | 2025-04-23 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement factor d medical disorders |
| CN113365617B (zh) | 2018-10-16 | 2025-12-23 | 乔治亚州立大学研究基金会股份有限公司 | 用于医学疾病治疗的一氧化碳前药 |
| KR102696616B1 (ko) | 2018-12-21 | 2024-08-20 | 한미약품 주식회사 | 흡입 제형용 건조 분말 및 이의 제조방법 |
| MX2021011507A (es) | 2019-03-22 | 2021-12-15 | Achillion Pharmaceuticals Inc | Compuestos farmaceuticos para el tratamiento de trastornos mediados por complemento. |
| KR102947433B1 (ko) | 2019-04-12 | 2026-04-06 | 씨4 테라퓨틱스, 인코포레이티드 | 이카로스 및 아이올로스의 트리시클릭 분해제 |
| US12269041B2 (en) | 2019-09-19 | 2025-04-08 | New Jersey Institute Of Technology | Spherical composite powder |
| KR102330428B1 (ko) | 2019-10-14 | 2021-11-24 | 한미약품 주식회사 | 흡입 제형용 건조 분말 및 이의 제조방법 |
| CN114845708A (zh) | 2019-12-19 | 2022-08-02 | 乔治亚州大学研究基金会 | 用于治疗细菌感染和增强抗生素的化合物 |
| JP2023515073A (ja) | 2020-02-20 | 2023-04-12 | アキリオン ファーマシューティカルズ， インコーポレーテッド | 補体因子ｄ媒介障害の処置用のヘテロアリール化合物 |
| CN119823124A (zh) | 2020-03-05 | 2025-04-15 | C4医药公司 | 用于brd9的靶向降解的化合物 |
| CA3193488A1 (en) | 2020-09-23 | 2022-03-31 | Jason Allan Wiles | Pharmaceutical compounds for the treatment of complement mediated disorders |
| CN119278026A (zh) | 2022-03-31 | 2025-01-07 | 好利安科技有限公司 | 吸入复合材料和基于载体的制剂组合 |
| AU2023406464A1 (en) | 2022-12-02 | 2025-07-17 | Kinaset Therapeutics, Inc. | Formulation of a pan-jak inhibitor |
| WO2024136219A1 (ko) * | 2022-12-19 | 2024-06-27 | 주식회사 포스테라헬스사이언스 | 나노 입자를 포함하는 흡입 제형 및 이의 제조 방법 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1381872A (en) | 1971-06-22 | 1975-01-29 | Fisons Ltd | Pharmaceutical compositions for inhalation |
| US4349542A (en) | 1979-06-08 | 1982-09-14 | National Research Development Corporation | Mixture containing active ingredient and dendritic crystalline sugar for tableting |
| IT1204826B (it) * | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
| SE8603812D0 (sv) | 1986-09-12 | 1986-09-12 | Draco Ab | Administration of liposomes to mammals |
| DE3917617A1 (de) * | 1989-05-31 | 1990-12-06 | Boehringer Ingelheim Kg | Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung |
| US5376386A (en) * | 1990-01-24 | 1994-12-27 | British Technology Group Limited | Aerosol carriers |
| WO1993025193A1 (fr) * | 1992-06-12 | 1993-12-23 | Teijin Limited | Preparation pharmaceutique destinee a etre administree par les voies respiratoires |
| GB2269992A (en) * | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
| US5506203C1 (en) * | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
| IS1796B (is) * | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
| AUPM414394A0 (en) * | 1994-02-28 | 1994-03-24 | Voxson International Pty. Limited | Multi-mode communications system |
| GB9501841D0 (en) * | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| US5612053A (en) * | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
| WO1996035516A1 (en) | 1995-05-09 | 1996-11-14 | Colorcon Limited | Electrostatic coating |
| GB9515182D0 (en) * | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| GB9526495D0 (en) | 1995-12-23 | 1996-02-28 | Knoll Ag | Therapeutic agents |
| US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US5955023A (en) * | 1996-11-27 | 1999-09-21 | Callutech, Llc | Method of forming composite particle products |
| DE69732306T2 (de) * | 1997-01-16 | 2006-01-12 | Massachusetts Institute Of Technology, Cambridge | Zubereitung von partikelhaltigen arzneimitteln zur inhalation |
| US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| GEP20043260B (en) * | 1998-03-16 | 2004-06-25 | Nectar Therapeutics | Aerosolized Active Agent Delivery and Device for Realization Thereof |
| AU749623B2 (en) * | 1998-03-26 | 2002-06-27 | Astellas Pharma Inc. | Sustained release preparations |
| US6428814B1 (en) * | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| CN1150895C (zh) | 1998-11-13 | 2004-05-26 | 杰格研究股份公司 | 用于吸入给药的干粉 |
| GB9826783D0 (en) | 1998-12-04 | 1999-01-27 | Scherer Ltd R P | Inhalation powders |
| GB9827145D0 (en) * | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
| IT1309592B1 (it) | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
| ATE289825T1 (de) | 1999-04-21 | 2005-03-15 | 1355540 Ontario Inc | Methacoline oder histamine formulierungen zur feststellung von asthma |
| DE60025019T2 (de) * | 1999-10-29 | 2006-08-24 | Nektar Therapeutics, San Carlos | Trockenpulverzusammensetzungen mit verbesserter dispersivität |
| GB0009468D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formulations for use in inhaler devices |
| GB0009469D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
| PE20011227A1 (es) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| ES2292598T3 (es) * | 2000-06-27 | 2008-03-16 | Vectura Limited | Metodo para producir particulas para usar en una composicion farmaceutica. |
| US8580306B2 (en) * | 2000-11-30 | 2013-11-12 | Vectura Limited | Particles for use in a pharmaceutical composition |
| EP2283817B1 (en) * | 2000-11-30 | 2016-05-18 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| US6966990B2 (en) | 2002-10-11 | 2005-11-22 | Ferro Corporation | Composite particles and method for preparing |
| US20060147389A1 (en) * | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
| US9192915B2 (en) * | 2008-05-10 | 2015-11-24 | Brigham Young University | Porous composite particulate materials, methods of making and using same, and related apparatuses |
| ES2440616T3 (es) * | 2010-01-27 | 2014-01-29 | Basf Se | Agente de recubrimiento que contiene partículas compuestas |
| US8491908B2 (en) * | 2010-06-01 | 2013-07-23 | Canon Kabushiki Kaisha | Composite particle, contrast agent for photoacoustic imaging, and method for producing the composite particle |
-
2001
- 2001-06-27 ES ES01947612T patent/ES2292598T3/es not_active Expired - Lifetime
- 2001-06-27 IL IL15370501A patent/IL153705A0/xx active IP Right Grant
- 2001-06-27 EP EP07120591.8A patent/EP1913939B1/en not_active Expired - Lifetime
- 2001-06-27 DK DK07120591.8T patent/DK1913939T3/en active
- 2001-06-27 AT AT01947612T patent/ATE378039T1/de active
- 2001-06-27 ES ES07120591.8T patent/ES2632461T3/es not_active Expired - Lifetime
- 2001-06-27 KR KR1020027017595A patent/KR100949539B1/ko not_active Expired - Lifetime
- 2001-06-27 EP EP10185471.9A patent/EP2266549B1/en not_active Revoked
- 2001-06-27 PT PT71205918T patent/PT1913939T/pt unknown
- 2001-06-27 CA CA2413692A patent/CA2413692C/en not_active Expired - Lifetime
- 2001-06-27 CN CNB018118887A patent/CN100551358C/zh not_active Expired - Lifetime
- 2001-06-27 WO PCT/GB2001/002860 patent/WO2002000197A1/en not_active Ceased
- 2001-06-27 DE DE60131399.2T patent/DE60131399T3/de not_active Expired - Lifetime
- 2001-06-27 EP EP01947612.6A patent/EP1296651B2/en not_active Expired - Lifetime
- 2001-06-27 PT PT01947612T patent/PT1296651E/pt unknown
- 2001-06-27 US US10/312,488 patent/US7744855B2/en not_active Expired - Fee Related
- 2001-06-27 JP JP2002504979A patent/JP5698423B2/ja not_active Expired - Lifetime
-
2002
- 2002-12-26 IL IL153705A patent/IL153705A/en unknown
-
2010
- 2010-05-18 US US12/782,283 patent/US9351928B2/en not_active Expired - Fee Related
-
2016
- 2016-05-02 US US15/144,770 patent/US20160243039A1/en not_active Abandoned
-
2017
- 2017-10-31 US US15/799,521 patent/US10561613B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2413692A1 (en) | Method of making particles for use in a pharmaceutical composition | |
| CA2406201A1 (en) | Improvements in or relating to formulations for use in inhaler devices | |
| JP5936353B2 (ja) | フルチカゾン粒子の結晶化度を改善する方法 | |
| US12233163B2 (en) | Crystalline microspheres and the process of manufacturing the same | |
| WO2005025506A3 (en) | Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation | |
| EP2286797A3 (en) | Dry powder composition comprising co-jet milled particles for pulmonary inhalation | |
| WO2007086039A1 (en) | A method of producing porous microparticles | |
| KR20140147891A (ko) | 응집체 입자 | |
| JP2006513236A5 (cg-RX-API-DMAC10.html) | ||
| NO315894B1 (no) | Blanding omfattende et virkestoff eller en virkestoffblanding, fremgangsmåte for fremstilling av en legemiddelformulering samt anvendelse avvirkestoffet eller virkestoffblandingen | |
| CN106615150A (zh) | 固体乳及用于制备固体乳的方法 | |
| EP2906205A1 (en) | Solventless mixing process for coating pharmaceutical ingredients | |
| JP2018188629A (ja) | 熱可塑性成形材料粉体の製造方法 | |
| JP2021510722A (ja) | ゲル製品の速溶性ブロックおよびその調製方法 | |
| JP4812211B2 (ja) | 低用量錠剤および調製方法 | |
| AU2003226842B2 (en) | A method for treating carrier particles and its use | |
| RU2569288C1 (ru) | Способ изготовления наноразмерного твердого сплава | |
| EP3520632A1 (en) | Spherical powder aggregate, and production method therefor | |
| JPH0558834A (ja) | 水溶性の非粉塵性埋没材及びその製法 | |
| CN107960634A (zh) | 一种利用多孔淀粉吸附脂质体温控释放香精香料的方法 | |
| JP4080920B2 (ja) | 液体凝結法による粉末顆粒の調製およびその粉末充填物の製造 | |
| DE502005002819D1 (de) | Verfahren zur Herstellung von keramischen Formkörpern auf Basis sinterfähiger Pulver | |
| JP4332562B2 (ja) | 製剤用核剤 | |
| JP2016034922A (ja) | 医薬品原末と医薬品添加剤の複合粒子の製造方法及び同方法で製造された複合粒子 | |
| JP2004160165A (ja) | 生薬成分製剤の造粒方法 |